Cargando…

Clinical significance of fluid biomarkers in Alzheimer’s Disease

ABSTRACT: The number of patients with Alzheimer’s Disease (AD) and other types of dementia disorders has drastically increased over the last decades. AD is a complex progressive neurodegenerative disease affecting about 14 million patients in Europe and the United States. The hallmarks of this disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewczuk, Piotr, Łukaszewicz-Zając, Marta, Mroczko, Piotr, Kornhuber, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329803/ https://www.ncbi.nlm.nih.gov/pubmed/32385624 http://dx.doi.org/10.1007/s43440-020-00107-0

Ejemplares similares

Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
por: Dulewicz, Maciej, et al.
Publicado: (2022)

Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment
por: Beata, Bocwinska-Kiluk, et al.
Publicado: (2023)

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
por: Mroczko, Barbara, et al.
Publicado: (2018)

The Significance of CXCL1 and CXCL8 as Well as Their Specific Receptors in Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2020)

Cerebrospinal fluid α synuclein concentrations in patients with positive AD biomarkers and extrapyramidal symptoms
por: Winkel, Izabela, et al.
Publicado: (2021)

Circulating Biomarkers of Colorectal Cancer (CRC)—Their Utility in Diagnosis and Prognosis
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

Perfusion Imaging with SPECT in the Era of Pathophysiology-Based Biomarkers for Alzheimer's Disease
por: Weih, Markus, et al.
Publicado: (2010)

CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression
por: Pączek, Sara, et al.
Publicado: (2020)

A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase (ADAM) Family—Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2022)

The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer
por: Pawluczuk, Elżbieta, et al.
Publicado: (2023)

Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
por: Baldeiras, Inês, et al.
Publicado: (2019)

The significance of chemokine CXCL-8 in esophageal carcinoma
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2020)

Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
por: Ouanes, Sami, et al.
Publicado: (2022)

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
por: Clark, Christopher, et al.
Publicado: (2021)

Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
por: Lewczuk, Piotr, et al.
Publicado: (2018)

Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2019)

Distributions of Aβ42 and Aβ42/40 in the Cerebrospinal Fluid in View of the Probability Theory
por: Lewczuk, Piotr, et al.
Publicado: (2021)

The Role of Chemokines in the Development of Gastric Cancer—Diagnostic and Therapeutic Implications
por: Pawluczuk, Elzbieta, et al.
Publicado: (2020)

Chemokines—What Is Their Role in Colorectal Cancer?
por: Pączek, Sara, et al.
Publicado: (2020)

Granzymes—Their Role in Colorectal Cancer
por: Pączek, Sara, et al.
Publicado: (2022)

The Significance of CXCL1 and CXCR1 as Potential Biomarkers of Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2023)

Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein
por: Spitzer, Philipp, et al.
Publicado: (2019)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
por: Lewczuk, Piotr, et al.
Publicado: (2018)

Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2010)

Cerebrospinal Fluid Aβ(42/40) Corresponds Better than Aβ(42) to Amyloid PET in Alzheimer’s Disease
por: Lewczuk, Piotr, et al.
Publicado: (2016)

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2014)

Molecular Aspects of a Diet as a New Pathway in the Prevention and Treatment of Alzheimer’s Disease
por: Doroszkiewicz, Julia, et al.
Publicado: (2023)

Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network
por: Benson, Gloria S., et al.
Publicado: (2022)

Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid
por: Mühle, Christiane, et al.
Publicado: (2013)

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
por: Kvartsberg, Hlin, et al.
Publicado: (2015)

Analysis of Surface Levels of IL-1 Receptors and Macrophage Scavenger Receptor I in Peripheral Immune Cells of Patients With Alzheimer Disease
por: Spitzer, Philipp, et al.
Publicado: (2019)

Combined Analysis of CSF Tau, Aβ42, Aβ1–42% and Aβ1–40(ox)% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia
por: Bibl, Mirko, et al.
Publicado: (2010)

The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2016)

Stem cell factor in the serum of patients with esophageal cancer in relation to its histological types
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2016)

Subfertility as Overlapping of Nutritional, Endocrine, Immune, and Cardiometabolic Dysregulations—A Study Focused on Biochemical Endophenotypes of Subfertile Couples
por: Wasilewski, Tadeusz, et al.
Publicado: (2023)

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use
por: d’Abramo, Cristina, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy
por: Sembill, Jochen A, et al.
Publicado: (2023)

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
por: Hellwig, Konstantin, et al.
Publicado: (2015)

CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD
por: Ermann, Natalia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c2i2gppv4acauv61k6muoqa3t5